Sinclair Method: A New Approach For Treating Alcoholism That Allows Patients To Drink In Moderation

Alcoholism is common in almost all countries and although it has shown several risks, some people still find it hard to control their drinking habits. However, this could be a thing of the past as a new treatment is being offered. Called the Sinclair method, the approach has been used in the 1979's that uses opioid-controlling drugs together with self-discipline and ironically, alcohol, to give alcoholics a better, new control.

The Sinclair Method boasts on its almost 80 percent of success rate and it uses a daily pill called Naltrexone for training the brain. It is recommended by NICE (National Institute for Health and Care Excellence) and functions by preventing the receptors from releasing alcohol-related endorphins. With long-term use, it ables a dramatic transformation of addictive behaviors for the better, while efficiently stopping alcohol addictions.

According to Daily Mail Online, one of its key selling points is that it provides a new alternative which is favorable for many alcoholics. Sinclair Method allows alcoholic to recover while still enjoying their favorite drinks such as wine, beer, and spirit, but in moderation. "'In some ways that's correct - alcohol can be evil in the wrong hands, but this treatment allows people to remain social and not to be fearful of public gatherings. That's much more realistic than total abstinence. People want that option," Dr. Josh Berkowitz said.

Most of Dr. Berkowitz agree and in fact, it has become the most popular treatment that has gotten over hundreds of people signing up. The Sinclair Method requires the patient to attend a clinic-based five-day detox which provides multi-vitamin and amino acid drips.

Next, alcoholic patients are introduced to Naltrexone together with small alcohol intake, as reported by Punch. The patients are encouraged to drink, in small amounts, for 10 days as this would lead their mind and body to experience their consumption of alcohol and the Naltrexone's experience.